Volume 3, Issue 11: Highlights from the 2014 EASL Meeting
e-Viral Hepatitis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Hepatitis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.
(Volume 3, Issue 11)
Target Audience
Nurses and health care professionals involved in the care of patients with Hepatitis.
Learning Objectives
After participating in this activity, the participant will demonstrate the ability to:
- Summarize recently released data about noninterferon-containing regimens for treating hepatitis C.
- Describe any performance gaps for interferon-free regimens in patients with cirrhosis.
- Describe the role of ribavirin as a component of HCV treatment in new interferon-free regimens.
- Describe newly presented information about noninvasive markers of liver disease.
Mark S. Sulkowski, MD
Professor of Medicine
Medical Director, Viral Hepatitis Center
Divisions of Infectious Diseases and Gastroenterology/Hepatology
The Johns Hopkins University School of Medicine
Baltimore, Maryland
Raymond T. Chung, MD
Associate Director of Medicine
Harvard Medical School
Director of Hepatology
Vice Chief of Gastroenterology
Massachusetts General Hospital
Boston, Massachusetts
Laurent Castera, MD, PhD
Department of Hepatology
Beaujon Hospital, AP-HP
INSERM U773
University of Paris-Diderot
Clichy, France
Available Credit
- 0.50 ANCC
- 0.50 Attendance